NSD2 silencing by specific short hairpin RNA (shRNA) inhibited prostate cancer cell growth, proliferation, and migration in vitro, and abrogated prostate cancer metastasis in vivo [18]. This evidence concerns the gene NSD2 and prostate carcinoma.